Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-03 Sale |
2025-01-07 8:00 pm |
AN2 Therapeutics Inc. | ANTX | Chanda Sanjay Chief Development Officer |
2,957 | $1.341 | $3,965 | 29,824 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-26 Option Award |
2025-02-28 4:27 pm |
N/A 2035-02-25 |
AN2 Therapeutics Inc. | ANTX | Chanda Sanjay Chief Development Officer |
150,750 | $0 | 180,574 (Direct) |
View |
| 2024-03-15 Option Award(A) |
2024-03-29 4:16 pm |
N/A N/A |
AN2 Therapeutics Inc. | ANTX | Chanda Sanjay Chief Development Officer |
27,500 | $0 | 28,235 (Direct) |
View |
| 2024-03-15 Option Award |
2024-03-18 7:27 pm |
N/A 2034-03-14 |
AN2 Therapeutics Inc. | ANTX | Chanda Sanjay Chief Development Officer |
82,500 | $0 | 83,235 (Direct) |
View |
| 2023-02-15 Option Award |
2023-02-17 7:28 pm |
N/A 2033-02-14 |
AN2 Therapeutics Inc. | ANTX | Chanda Sanjay Chief Development Officer |
57,950 | $0 | 57,950 (Direct) |
View |
| 2022-05-12 Option Award |
2022-05-16 9:32 pm |
N/A 2032-05-11 |
AN2 Therapeutics Inc. | ANTX | Chanda Sanjay Chief Development Officer |
66,000 | $0 | 66,000 (Direct) |
View |
Ownership |
2022-03-24 9:19 pm |
N/A 2030-01-22 |
AN2 Therapeutics Inc. | ANTX | Chanda Sanjay Chief Development Officer |
0 | $0 | 141,581 (Direct) |
View |